25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

BioLargo Inc
Buy, Hold or Sell?

Let's analyze Biolargo together

I guess you are interested in BioLargo Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of BioLargo Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about BioLargo Inc

I send you an email if I find something interesting about BioLargo Inc.

1. Quick Overview

1.1. Quick analysis of Biolargo (30 sec.)










1.2. What can you expect buying and holding a share of Biolargo? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.01
Expected worth in 1 year
$0.02
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
$0.01
Return On Investment
8.1%

For what price can you sell your share?

Current Price per Share
$0.18
Expected price per share
$0.17 - $0.21
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Biolargo (5 min.)




Live pricePrice per Share (EOD)
$0.18
Intrinsic Value Per Share
$-0.06 - $-0.03
Total Value Per Share
$-0.06 - $-0.03

2.2. Growth of Biolargo (5 min.)




Is Biolargo growing?

Current yearPrevious yearGrowGrow %
How rich?$2m$933k$1m53.6%

How much money is Biolargo making?

Current yearPrevious yearGrowGrow %
Making money-$4.4m-$7m$2.6m58.3%
Net Profit Margin-76.0%-279.7%--

How much money comes from the company's main activities?

2.3. Financial Health of Biolargo (5 min.)




2.4. Comparing to competitors in the Chemicals industry (5 min.)




  Industry Rankings (Chemicals)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Biolargo?

Welcome investor! Biolargo's management wants to use your money to grow the business. In return you get a share of Biolargo.

First you should know what it really means to hold a share of Biolargo. And how you can make/lose money.

Speculation

The Price per Share of Biolargo is $0.177. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biolargo.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biolargo, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.01. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biolargo.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.01-8.4%-0.01-8.4%-0.02-13.3%-0.03-15.4%-0.02-12.5%
Usd Book Value Change Per Share0.002.0%0.002.0%0.002.2%0.002.0%0.000.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.002.0%0.002.0%0.002.2%0.002.0%0.000.4%
Usd Price Per Share0.19-0.19-0.21-0.20-0.32-
Price to Earnings Ratio-12.77--12.77--8.92--7.82--13.85-
Price-to-Total Gains Ratio52.98-52.98-54.05-19.13-28.61-
Price to Book Ratio28.40-28.40-67.66--30.27--74.71-
Price-to-Total Gains Ratio52.98-52.98-54.05-19.13-28.61-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.177
Number of shares5649
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (5649 shares)20.2620.37
Gains per Year (5649 shares)81.0381.49
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10817108171
201621520163152
302432330244233
403243140326314
504053950407395
604864760489476
705675570570557
806486380652638
907297190733719
1008108000815800

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.09.01.00.0%0.09.014.00.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%6.04.00.060.0%12.011.00.052.2%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.023.00.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%4.01.00.080.0%6.04.00.060.0%12.011.00.052.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of BioLargo Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0040.0040%0.004-8%0.004-1%0.001+369%
Book Value Per Share--0.0070.0070%0.003+116%0.000+106%-0.002+123%
Current Ratio--2.0012.0010%1.311+53%0.873+129%1.085+84%
Debt To Asset Ratio--0.5860.5860%0.691-15%1.056-44%1.721-66%
Debt To Equity Ratio--0.5840.5840%0.449+30%0.475+23%0.466+25%
Dividend Per Share----0%-0%-0%-0%
Eps---0.015-0.0150%-0.024+58%-0.027+83%-0.022+49%
Free Cash Flow Per Share---0.010-0.0100%-0.013+31%-0.013+29%-0.012+15%
Free Cash Flow To Equity Per Share--0.0030.0030%0.001+255%0.001+340%0.001+341%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.900+11%
Intrinsic Value_10Y_max---0.035--------
Intrinsic Value_10Y_min---0.064--------
Intrinsic Value_1Y_max---0.011--------
Intrinsic Value_1Y_min---0.011--------
Intrinsic Value_3Y_max---0.026--------
Intrinsic Value_3Y_min---0.030--------
Intrinsic Value_5Y_max---0.036--------
Intrinsic Value_5Y_min---0.045--------
Market Cap53209564.416-7%57117611.52057117611.5200%63129991.680-10%58650768.461-3%97626022.848-41%
Net Profit Margin---0.760-0.7600%-2.797+268%-4.052+433%-13.841+1721%
Operating Margin---0.872-0.8720%-2.518+189%-2.935+237%-10.655+1122%
Operating Ratio--2.3842.3840%4.060-41%4.397-46%12.018-80%
Pb Ratio26.459-7%28.40328.4030%67.663-58%-30.268+207%-74.713+363%
Pe Ratio-11.896+7%-12.769-12.7690%-8.917-30%-7.817-39%-13.846+8%
Price Per Share0.177-7%0.1900.1900%0.210-10%0.195-3%0.325-41%
Price To Free Cash Flow Ratio-17.544+7%-18.832-18.8320%-15.898-16%-15.233-19%-29.834+58%
Price To Total Gains Ratio49.360-7%52.98552.9850%54.050-2%19.127+177%28.614+85%
Quick Ratio--0.6750.6750%0.373+81%0.274+146%0.155+336%
Return On Assets---0.921-0.9210%-2.342+154%-2.226+142%-3.773+310%
Return On Equity---0.917-0.9170%-1.522+66%-0.925+1%-1.900+107%
Total Gains Per Share--0.0040.0040%0.004-8%0.004-1%0.001+369%
Usd Book Value--2011000.0002011000.0000%933000.000+116%-118800.000+106%-458945.100+123%
Usd Book Value Change Per Share--0.0040.0040%0.004-8%0.004-1%0.001+369%
Usd Book Value Per Share--0.0070.0070%0.003+116%0.000+106%-0.002+123%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.015-0.0150%-0.024+58%-0.027+83%-0.022+49%
Usd Free Cash Flow---3033000.000-3033000.0000%-3971000.000+31%-3917400.000+29%-3140735.400+4%
Usd Free Cash Flow Per Share---0.010-0.0100%-0.013+31%-0.013+29%-0.012+15%
Usd Free Cash Flow To Equity Per Share--0.0030.0030%0.001+255%0.001+340%0.001+341%
Usd Market Cap53209564.416-7%57117611.52057117611.5200%63129991.680-10%58650768.461-3%97626022.848-41%
Usd Price Per Share0.177-7%0.1900.1900%0.210-10%0.195-3%0.325-41%
Usd Profit---4473000.000-4473000.0000%-7080000.000+58%-8179200.000+83%-6660112.700+49%
Usd Revenue--5884000.0005884000.0000%2531000.000+132%2814400.000+109%1527690.100+285%
Usd Total Gains Per Share--0.0040.0040%0.004-8%0.004-1%0.001+369%
 EOD+2 -6MRQTTM+0 -0YOY+24 -95Y+24 -910Y+27 -7

3.3 Fundamental Score

Let's check the fundamental score of BioLargo Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-11.896
Price to Book Ratio (EOD)Between0-126.459
Net Profit Margin (MRQ)Greater than0-0.760
Operating Margin (MRQ)Greater than0-0.872
Quick Ratio (MRQ)Greater than10.675
Current Ratio (MRQ)Greater than12.001
Debt to Asset Ratio (MRQ)Less than10.586
Debt to Equity Ratio (MRQ)Less than10.584
Return on Equity (MRQ)Greater than0.15-0.917
Return on Assets (MRQ)Greater than0.05-0.921
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of BioLargo Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5029.102
Ma 20Greater thanMa 500.206
Ma 50Greater thanMa 1000.227
Ma 100Greater thanMa 2000.240
OpenGreater thanClose0.180
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About BioLargo Inc

BioLargo, Inc. invents, develops, and commercializes various platform technologies. Its technologies solve challenging environmental problems comprising per - and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation. The company provides full-service environmental engineering services. BioLargo, Inc. was incorporated in 1991 and is based in Westminster, California.

Fundamental data was last updated by Penke on 2024-11-03 02:27:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Biolargo earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Biolargo to the Chemicals industry mean.
  • A Net Profit Margin of -76.0% means that $-0.76 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of BioLargo Inc:

  • The MRQ is -76.0%. The company is making a huge loss. -2
  • The TTM is -76.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-76.0%TTM-76.0%0.0%
TTM-76.0%YOY-279.7%+203.7%
TTM-76.0%5Y-405.2%+329.2%
5Y-405.2%10Y-1,384.1%+978.8%
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ-76.0%3.3%-79.3%
TTM-76.0%2.3%-78.3%
YOY-279.7%4.3%-284.0%
5Y-405.2%4.9%-410.1%
10Y-1,384.1%5.2%-1,389.3%
4.3.1.2. Return on Assets

Shows how efficient Biolargo is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biolargo to the Chemicals industry mean.
  • -92.1% Return on Assets means that Biolargo generated $-0.92 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of BioLargo Inc:

  • The MRQ is -92.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -92.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-92.1%TTM-92.1%0.0%
TTM-92.1%YOY-234.2%+142.1%
TTM-92.1%5Y-222.6%+130.5%
5Y-222.6%10Y-377.3%+154.7%
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ-92.1%0.7%-92.8%
TTM-92.1%0.6%-92.7%
YOY-234.2%0.9%-235.1%
5Y-222.6%1.1%-223.7%
10Y-377.3%1.2%-378.5%
4.3.1.3. Return on Equity

Shows how efficient Biolargo is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biolargo to the Chemicals industry mean.
  • -91.7% Return on Equity means Biolargo generated $-0.92 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of BioLargo Inc:

  • The MRQ is -91.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -91.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-91.7%TTM-91.7%0.0%
TTM-91.7%YOY-152.2%+60.5%
TTM-91.7%5Y-92.5%+0.8%
5Y-92.5%10Y-190.0%+97.5%
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ-91.7%1.3%-93.0%
TTM-91.7%1.1%-92.8%
YOY-152.2%1.6%-153.8%
5Y-92.5%1.9%-94.4%
10Y-190.0%2.2%-192.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of BioLargo Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Biolargo is operating .

  • Measures how much profit Biolargo makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biolargo to the Chemicals industry mean.
  • An Operating Margin of -87.2% means the company generated $-0.87  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of BioLargo Inc:

  • The MRQ is -87.2%. The company is operating very inefficient. -2
  • The TTM is -87.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-87.2%TTM-87.2%0.0%
TTM-87.2%YOY-251.8%+164.6%
TTM-87.2%5Y-293.5%+206.3%
5Y-293.5%10Y-1,065.5%+772.0%
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ-87.2%4.8%-92.0%
TTM-87.2%3.5%-90.7%
YOY-251.8%4.2%-256.0%
5Y-293.5%6.4%-299.9%
10Y-1,065.5%5.9%-1,071.4%
4.3.2.2. Operating Ratio

Measures how efficient Biolargo is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Chemicals industry mean).
  • An Operation Ratio of 2.38 means that the operating costs are $2.38 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of BioLargo Inc:

  • The MRQ is 2.384. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.384. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.384TTM2.3840.000
TTM2.384YOY4.060-1.676
TTM2.3845Y4.397-2.013
5Y4.39710Y12.018-7.621
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3841.701+0.683
TTM2.3841.672+0.712
YOY4.0601.601+2.459
5Y4.3971.573+2.824
10Y12.0181.297+10.721
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of BioLargo Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Biolargo is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Chemicals industry mean).
  • A Current Ratio of 2.00 means the company has $2.00 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of BioLargo Inc:

  • The MRQ is 2.001. The company is able to pay all its short-term debts. +1
  • The TTM is 2.001. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.001TTM2.0010.000
TTM2.001YOY1.311+0.690
TTM2.0015Y0.873+1.128
5Y0.87310Y1.085-0.212
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0011.490+0.511
TTM2.0011.557+0.444
YOY1.3111.668-0.357
5Y0.8731.786-0.913
10Y1.0851.616-0.531
4.4.3.2. Quick Ratio

Measures if Biolargo is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biolargo to the Chemicals industry mean.
  • A Quick Ratio of 0.68 means the company can pay off $0.68 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of BioLargo Inc:

  • The MRQ is 0.675. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.675. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.675TTM0.6750.000
TTM0.675YOY0.373+0.302
TTM0.6755Y0.274+0.401
5Y0.27410Y0.155+0.119
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6750.547+0.128
TTM0.6750.623+0.052
YOY0.3730.809-0.436
5Y0.2740.854-0.580
10Y0.1550.861-0.706
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of BioLargo Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Biolargo assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biolargo to Chemicals industry mean.
  • A Debt to Asset Ratio of 0.59 means that Biolargo assets are financed with 58.6% credit (debt) and the remaining percentage (100% - 58.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of BioLargo Inc:

  • The MRQ is 0.586. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.586. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.586TTM0.5860.000
TTM0.586YOY0.691-0.105
TTM0.5865Y1.056-0.470
5Y1.05610Y1.721-0.665
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5860.442+0.144
TTM0.5860.434+0.152
YOY0.6910.416+0.275
5Y1.0560.413+0.643
10Y1.7210.409+1.312
4.5.4.2. Debt to Equity Ratio

Measures if Biolargo is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biolargo to the Chemicals industry mean.
  • A Debt to Equity ratio of 58.4% means that company has $0.58 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of BioLargo Inc:

  • The MRQ is 0.584. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.584. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.584TTM0.5840.000
TTM0.584YOY0.449+0.134
TTM0.5845Y0.475+0.109
5Y0.47510Y0.466+0.009
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5840.833-0.249
TTM0.5840.832-0.248
YOY0.4490.757-0.308
5Y0.4750.763-0.288
10Y0.4660.829-0.363
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Biolargo generates.

  • Above 15 is considered overpriced but always compare Biolargo to the Chemicals industry mean.
  • A PE ratio of -12.77 means the investor is paying $-12.77 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of BioLargo Inc:

  • The EOD is -11.896. Based on the earnings, the company is expensive. -2
  • The MRQ is -12.769. Based on the earnings, the company is expensive. -2
  • The TTM is -12.769. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-11.896MRQ-12.769+0.874
MRQ-12.769TTM-12.7690.000
TTM-12.769YOY-8.917-3.853
TTM-12.7695Y-7.817-4.953
5Y-7.81710Y-13.846+6.029
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD-11.89613.850-25.746
MRQ-12.76914.149-26.918
TTM-12.76913.389-26.158
YOY-8.91713.674-22.591
5Y-7.81714.845-22.662
10Y-13.84622.448-36.294
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of BioLargo Inc:

  • The EOD is -17.544. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -18.832. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -18.832. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-17.544MRQ-18.832+1.289
MRQ-18.832TTM-18.8320.000
TTM-18.832YOY-15.898-2.934
TTM-18.8325Y-15.233-3.599
5Y-15.23310Y-29.834+14.600
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD-17.5442.776-20.320
MRQ-18.8323.161-21.993
TTM-18.8320.008-18.840
YOY-15.898-0.353-15.545
5Y-15.2330.313-15.546
10Y-29.8341.407-31.241
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Biolargo is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Chemicals industry mean).
  • A PB ratio of 28.40 means the investor is paying $28.40 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of BioLargo Inc:

  • The EOD is 26.459. Based on the equity, the company is expensive. -2
  • The MRQ is 28.403. Based on the equity, the company is expensive. -2
  • The TTM is 28.403. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD26.459MRQ28.403-1.943
MRQ28.403TTM28.4030.000
TTM28.403YOY67.663-39.261
TTM28.4035Y-30.268+58.671
5Y-30.26810Y-74.713+44.445
Compared to industry (Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD26.4591.360+25.099
MRQ28.4031.290+27.113
TTM28.4031.380+27.023
YOY67.6631.644+66.019
5Y-30.2681.711-31.979
10Y-74.7132.228-76.941
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Total Other Income Expense Net -1,021-8-1,029587-442100-34238240



6.2. Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets4,858
Total Liabilities2,847
Total Stockholder Equity4,878
 As reported
Total Liabilities 2,847
Total Stockholder Equity+ 4,878
Total Assets = 4,858

Assets

Total Assets4,858
Total Current Assets3,153
Long-term Assets1,705
Total Current Assets
Cash And Cash Equivalents 1,851
Net Receivables 1,064
Inventory 120
Other Current Assets 118
Total Current Assets  (as reported)3,153
Total Current Assets  (calculated)3,153
+/-0
Long-term Assets
Property Plant Equipment 1,154
Long Term Investments 33
Intangible Assets 34
Long-term Assets  (as reported)1,705
Long-term Assets  (calculated)1,221
+/- 484

Liabilities & Shareholders' Equity

Total Current Liabilities1,576
Long-term Liabilities1,271
Total Stockholder Equity4,878
Total Current Liabilities
Short Long Term Debt 100
Accounts payable 903
Other Current Liabilities 184
Total Current Liabilities  (as reported)1,576
Total Current Liabilities  (calculated)1,187
+/- 389
Long-term Liabilities
Long term Debt 498
Capital Lease Obligations Min Short Term Debt870
Long-term Liabilities  (as reported)1,271
Long-term Liabilities  (calculated)1,368
+/- 97
Total Stockholder Equity
Total Stockholder Equity (as reported)4,878
Total Stockholder Equity (calculated)0
+/- 4,878
Other
Capital Stock186
Common Stock Shares Outstanding 278,463
Net Invested Capital 5,476
Net Tangible Assets 4,878
Net Working Capital 1,577
Property Plant and Equipment Gross 1,154



6.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
> Total Assets 
10,248
4,590
4,374
1
0
283
246
11,458
10,009
181
460
246
269
167
261
1,910
2,113
1,495
3,185
3,621
4,942
3,023
4,858
4,8583,0234,9423,6213,1851,4952,1131,91026116726924646018110,00911,458246283014,3744,59010,248
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
231
1,891
2,017
1,158
955
1,065
1,505
1,801
3,153
3,1531,8011,5051,0659551,1582,0171,89123100000000000000
       Cash And Cash Equivalents 
4,422
441
1
1
0
283
229
457
90
134
425
129
151
92
154
1,763
1,910
990
655
655
716
962
1,851
1,8519627166556559901,9101,76315492151129425134904572292830114414,422
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
41
68
94
257
355
484
513
1,064
1,064513484355257946841600000000000000
       Other Current Assets 
137
157
0
0
0
0
17
5
5
6
4
1
0
0
45
919
0
0
0
39
28
85
118
118852839000919450014655170000157137
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
96
337
2,230
2,556
3,437
1,222
1,705
1,7051,2223,4372,5562,230337960000000000000000
       Property Plant Equipment 
3,709
2,360
29
0
0
0
0
0
26
17
7
3
0
0
0
0
59
109
126
506
401
514
1,154
1,15451440150612610959000037172600000292,3603,709
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
63
48
33
33486300000000000000000000
       Intangible Assets 
0
0
4,344
0
0
0
0
10,996
9,888
0
0
0
0
0
30
19
37
0
1,893
1,893
2,150
34
34
34342,1501,8931,8930371930000009,88810,99600004,34400
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
37
33
35
35
35
69
0
06935353533370000000000000000
> Total Liabilities 
3,626
3,385
2,401
2,925
3,708
5,074
5,575
2,422
2,655
4,044
3,053
1,764
558
732
653
769
2,883
4,905
4,308
5,801
5,177
2,090
2,847
2,8472,0905,1775,8014,3084,9052,8837696537325581,7643,0534,0442,6552,4225,5755,0743,7082,9252,4013,3853,626
   > Total Current Liabilities 
3,626
3,385
2,401
2,925
3,708
5,074
5,347
1,496
2,082
3,465
2,389
1,374
558
732
653
460
1,155
4,216
2,491
4,354
3,544
1,374
1,576
1,5761,3743,5444,3542,4914,2161,1554606537325581,3742,3893,4652,0821,4965,3475,0743,7082,9252,4013,3853,626
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
58
0
0
0
0
3,592
0
0
0
0003,59200005800000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
58
5,797
610
3,992
1,990
3,592
2,333
314
100
1003142,3333,5921,9903,9926105,7975800000000000000
       Accounts payable 
191
986
1,132
1,256
2,055
2,313
32
230
303
479
519
448
334
362
313
175
22
88
302
403
717
499
903
9034997174033028822175313362334448519479303230322,3132,0551,2561,132986191
       Other Current Liabilities 
0
0
0
0
0
0
2,280
1,187
1,348
1,543
325
412
124
45
282
135
801
0
0
35
48
168
184
184168483500801135282451244123251,5431,3481,1872,280000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,728
689
1,817
1,447
1,633
716
1,271
1,2717161,6331,4471,8176891,7280000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
643
643
900
0
0
00900643643000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
195
2,069
2,015
2,150
0
0
002,1502,0152,06919500000000000000000
> Total Stockholder Equity
6,622
1,205
1,973
0
0
0
0
9,036
7,407
0
0
0
0
0
-453
352
-1,325
-4,104
-1,496
-2,153
3,858
4,653
4,878
4,8784,6533,858-2,153-1,496-4,104-1,325352-453000007,4079,03600001,9731,2056,622
   Common Stock
3
3
11
24
34
41
52
77
28
29
35
40
47
50
55
57
62
70
95
111
151
171
0
0171151111957062575550474035292877524134241133
   Retained Earnings Total Equity00000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000
   Capital Surplus 00000000000000000000000
   Treasury Stock0000000000000000000-127-127-127-5
   Other Stockholders Equity 0-115-101-99-90-62-82-41000000000000000



6.4. Balance Sheets

Currency in USD. All numbers in thousands.




6.5. Cash Flows

Currency in USD. All numbers in thousands.




6.6. Income Statements

Currency in USD. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue9,958
Cost of Revenue-4,927
Gross Profit5,0315,031
 
Operating Income (+$)
Gross Profit5,031
Operating Expense-14,714
Operating Income-4,756-9,683
 
Operating Expense (+$)
Research Development2,147
Selling General Administrative7,678
Selling And Marketing Expenses-
Operating Expense14,7149,825
 
Net Interest Income (+$)
Interest Income-
Interest Expense-83
Other Finance Cost-0
Net Interest Income-83
 
Pretax Income (+$)
Operating Income-4,756
Net Interest Income-83
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-5,036-4,756
EBIT - interestExpense = -83
-3,864
-3,781
Interest Expense83
Earnings Before Interest and Taxes (EBIT)--4,953
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-5,036
Tax Provision--
Net Income From Continuing Ops-5,036-5,036
Net Income-3,864
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-83
 

Technical Analysis of Biolargo
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biolargo. The general trend of Biolargo is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biolargo's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of BioLargo Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.18 < 0.21 < 0.21.

The bearish price targets are: 0.17 > 0.17 > 0.17.

Tweet this
BioLargo Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of BioLargo Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

BioLargo Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of BioLargo Inc. The current macd is -0.01416214.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Biolargo price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Biolargo. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Biolargo price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
BioLargo Inc Daily Moving Average Convergence/Divergence (MACD) ChartBioLargo Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of BioLargo Inc. The current adx is 41.12.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Biolargo shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
BioLargo Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of BioLargo Inc. The current sar is 0.2.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
BioLargo Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of BioLargo Inc. The current rsi is 29.10. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
BioLargo Inc Daily Relative Strength Index (RSI) ChartBioLargo Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of BioLargo Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Biolargo price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
BioLargo Inc Daily Stochastic Oscillator ChartBioLargo Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of BioLargo Inc. The current cci is -107.78872518.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
BioLargo Inc Daily Commodity Channel Index (CCI) ChartBioLargo Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of BioLargo Inc. The current cmo is -43.94502223.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
BioLargo Inc Daily Chande Momentum Oscillator (CMO) ChartBioLargo Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of BioLargo Inc. The current willr is -88.33333333.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
BioLargo Inc Daily Williams %R ChartBioLargo Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of BioLargo Inc.

BioLargo Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of BioLargo Inc. The current atr is 0.01142703.

BioLargo Inc Daily Average True Range (ATR) ChartBioLargo Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of BioLargo Inc. The current obv is -1,528,732.

BioLargo Inc Daily On-Balance Volume (OBV) ChartBioLargo Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of BioLargo Inc. The current mfi is 14.60.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
BioLargo Inc Daily Money Flow Index (MFI) ChartBioLargo Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for BioLargo Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-07-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-10MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-12MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-05STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-09-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-09-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-27MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-02STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-10-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-23MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-24STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-30BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-04BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-05RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-06STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

BioLargo Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of BioLargo Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5029.102
Ma 20Greater thanMa 500.206
Ma 50Greater thanMa 1000.227
Ma 100Greater thanMa 2000.240
OpenGreater thanClose0.180
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Biolargo with someone you think should read this too:
  • Are you bullish or bearish on Biolargo? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biolargo? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about BioLargo Inc

I send you an email if I find something interesting about BioLargo Inc.


Comments

How you think about this?

Leave a comment

Stay informed about BioLargo Inc.

Receive notifications about BioLargo Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.